AMD (AMD) Upgraded by Analysts on Inferencing Potential

Author's Avatar
Jun 28, 2025
Article's Main Image

Summary:

  • Melius Research upgrades Advanced Micro Devices (AMD, Financial) to a "Buy" rating with a boosted price target of $175, driven by robust GPU demand projections.
  • Analysts anticipate a sustained demand surge, particularly in inferencing, between 2026 and 2028.
  • GuruFocus estimates suggest AMD's fair value indicates a potential upside of over 15% from the current price.

Melius Research has recently upgraded Advanced Micro Devices (AMD) to a "Buy" status, showcasing confidence in the company's trajectory, especially in the inferencing sector. With an increased price target set at $175, AMD's GPU prospects are highlighted, reinforcing the anticipation of a sustainable demand surge that could span from 2026 to 2028.

Wall Street Analysts Forecast

1938961386973589504.png

Recent analysis by 40 Wall Street analysts suggests that the average target price for Advanced Micro Devices Inc (AMD, Financial) is $131.51. This forecast comes with high and low estimates set at $200.00 and $95.00, respectively. The average target implies a possible downside of 8.55% from the current trading price of $143.81. For more detailed estimates, refer to the Advanced Micro Devices Inc (AMD) Forecast page.

The consensus from 52 brokerage firms currently places AMD at an average recommendation rating of 2.1, which indicates an "Outperform" status. This rating scale, from 1 to 5, categorizes 1 as a Strong Buy and 5 as Sell, reflecting analysts' positive outlook for AMD.

Furthermore, based on GuruFocus estimates, the projected GF Value for AMD in one year stands at $165.64. This suggests a significant upside potential of 15.18% from its current market price of $143.81. The GF Value is GuruFocus's calculated estimation of a stock's fair value, leveraging historical trading multiples, past business growth, and future business performance projections. For more detailed insights, visit the Advanced Micro Devices Inc (AMD, Financial) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.